Literature DB >> 2050389

Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation.

D F Purcell1, S M Russell, N J Deacon, M A Brown, D J Hooker, I F McKenzie.   

Abstract

Five alternative cDNA clones were isolated for CD46, also known as the membrane cofactor protein (MCP) for the factor I-mediated cleavage of the complement convertases. One of these cDNA clones (a) was identical to an earlier MCP clone. The other four CD46 clones contained the four NH2-terminal short consensus repeat (SCR) units of MCP, but differed at the region encoding the carboxyl-terminal of the protein which includes an extracellular segment rich in Ser, Thr, and Pro residues, a hydrophobic membrane-spanning domain, and a 33 amino acid cytoplasmic tail. The different CD46 cDNAs have variously: (b) inserted a 93 base pair (bp) exon resulting in a new cytoplasmic tail of 26 amino acids; (c) deleted a 42 bp exon from the extracellular Ser/Thr rich region: (d) used a cryptic splice acceptor sequence to delete 37 bp from an exon encoding transmembrane sequence; or (e) failed to splice the intron after the four SCR units. These were shown by northern blot and polymerase chain reaction to arise by alternative splicing of CD46 RNA. Forms (a), (b), and (c) of CD46 RNA are common in placental RNA, but (d) was rare, and (e) was incompletely processed and therefore aberrant. The polymerase chain reaction (PCR) was used to map the sites of the intron/exon junctions and demonstrate further possible splice variants of CD46. The alternative RNAs for CD46 may correlate to the different isoforms of CD46 found in different tissues, tumors, and in serum.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050389     DOI: 10.1007/bf00216692

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  35 in total

1.  Variability of CR2 gene products is due to alternative exon usage and different CR2 alleles.

Authors:  L E Toothaker; A J Henjes; J J Weis
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

Review 2.  In search of trophoblast-lymphocyte crossreactive (TLX) antigens.

Authors:  J A McIntyre
Journal:  Am J Reprod Immunol Microbiol       Date:  1988-07

3.  Hu Ly-m5: a unique antigen physically associated with HLA molecules.

Authors:  R L Sparrow; I F McKenzie
Journal:  Hum Immunol       Date:  1983-05       Impact factor: 2.850

4.  Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.

Authors:  A Nicholson-Weller; J Burge; D T Fearon; P F Weller; K F Austen
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  Biochemical characterization of membrane cofactor protein of the complement system.

Authors:  L L Ballard; N S Bora; G H Yu; J P Atkinson
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

6.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

7.  Human non-lineage antigen, CD46 (HuLy-m5): purification and partial sequencing demonstrates structural homology with complement-regulating glycoproteins.

Authors:  D F Purcell; N J Deacon; S M Andrew; I F McKenzie
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

8.  Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins.

Authors:  I W Caras; M A Davitz; L Rhee; G Weddell; D W Martin; V Nussenzweig
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

9.  Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens.

Authors:  M Streuli; L R Hall; Y Saga; S F Schlossman; H Saito
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

Authors:  T Seya; J R Turner; J P Atkinson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more
  22 in total

1.  Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding.

Authors:  E C Hsu; R E Dörig; F Sarangi; A Marcil; C Iorio; C D Richardson
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Strong associations between RFLP and protein polymorphisms for CD46.

Authors:  A N Wilton; R W Johnstone; I F McKenzie; D F Purcell
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Localization of regions in CD46 that interact with adenovirus.

Authors:  Anuj Gaggar; Dmitry M Shayakhmetov; M Kathryn Liszewski; John P Atkinson; André Lieber
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  1. Alternative splicing of viral receptors: A review of the diverse morphologies and physiologies of adenoviral receptors.

Authors:  Katherine J D A Excoffon; Jonathan R Bowers; Priyanka Sharma
Journal:  Recent Res Dev Virol       Date:  2014

5.  Engineering of recombinant soluble CD46: an inhibitor of complement activation.

Authors:  D Christiansen; J Milland; B R Thorley; I F McKenzie; P L Mottram; L J Purcell; B E Loveland
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

Review 6.  CD46 processing: a means of expression.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Immunobiology       Date:  2011-07-13       Impact factor: 3.144

Review 7.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

Review 8.  T-cell regulation by CD46 and its relevance in multiple sclerosis.

Authors:  Anne L Astier
Journal:  Immunology       Date:  2008-04-02       Impact factor: 7.397

9.  Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46.

Authors:  Yasuko Mori; Tsukasa Seya; Hong Lan Huang; Pilailuk Akkapaiboon; Panadda Dhepakson; Koichi Yamanishi
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Post-translational modification and intracellular localization of a splice product of CD46 cloned from human testis: role of the intracellular domains in O-glycosylation.

Authors:  T Hara; Y Suzuki; T Nakazawa; H Nishimura; S Nagasawa; M Nishiguchi; M Matsumoto; M Hatanaka; M Kitamura; T Seya
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.